Overview

The Effect of Montelukast Treatment in Wheezy Infants

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The study is designed to evaluate the efficacy of montelukast on symptom-free days in unselected group of very young children with wheeze and recurrent asthma like symptoms. The secondary aim was to evaluate the effect of montelukast on lung function, airway responsiveness, airway inflammation and use of rescue medication.
Phase:
Phase 4
Details
Lead Sponsor:
Helsinki University
University of Helsinki
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast